Manufacturer profileCID S.p.A.
Myanmar3 devices2 brandsJan 06, 2022 – Dec 07, 2022
VerifiedFDA Myanmar · official registry
3
Total devices
2
Brands
2022
Earliest
2022
Latest
Regulatory footprint
Search CID S.p.A. across other regulatory registries
Thailand
European Union
Colombia
South Korea
Canada
EcuadorRecent registrations
Latest 10 FDA device registrations
Amphilimus (Sirolimus + Organic Acid) Eluting Coronary Stent
Dec 07, 2022
- Brand
- CRE8
- Analysis ID
- 7dde4b853abd384ec073308f82f84068
Amphilimus (Sirolimus + Organic Acid) Eluting Coronary Stents (20-sizes)
Feb 02, 2022
- Brand
- CRE8 Brand
- Analysis ID
- 097c88d4348755e13b3368f0be2d8fc7
Sirolimus Eluting Carbofilm Coated Coronary Stents (20-sizes)
Jan 06, 2022
- Brand
- CRE8 Brand
- Analysis ID
- d3488f383037fb3d1af1aaa11a2d718e
About this profile
Explore comprehensive manufacturer profile for CID S.p.A. through Pure Global AI's free Myanmar medical device database. This company manufactures 3 medical devices across 2 brands registered with FDA. Their registration history spans from Jan 06, 2022 to Dec 07, 2022.